Radiotherapy Improves Survival in Difficult Liver Cancer Cases
Stereotactic body radiotherapy plus sorafenib led to a strong survival benefit vs sorafenib alone in advanced hepatocellular carcinoma. MDedge News
Antiviral Therapy Improves Survival After Liver Cancer Surgery
The analysis focused on elderly patients after hepatectomy for hepatitis B virus–related hepatocellular carcinoma. The study was published as a preprint and has not yet been peer reviewed. First Look
Novel Blood Test for Early-Stage Liver Cancer Shows Promise
The blood test identifies early-stage hepatocellular carcinoma in patients at risk with around 90% accuracy and could augment current surveillance methods and improve patient outcomes. Medscape Medical News
Pervasive 'Forever Chemical' Linked to Liver Cancer
Exposure to perfluorooctane sulfonic acid correlates with an elevated risk for hepatocellular carcinoma. Medscape Medical News
Neighborhood Factors Contribute to Liver Cancer Disparities
Texas has the highest rate of hepatocellular carcinoma in the United States, and new research sheds light on why incidence rates vary across the state by race, ethnicity, and geographic location. Medscape Medical News
Treatment Combo Shows 'Clinical Benefit' in Liver Cancer Trial
The combination of a tyrosine kinase inhibitor with an immune checkpoint inhibitor significantly improved progression-free survival in patients with hepatocellular carcinoma, shows a new study. MDedge News
High Residual Liver Cancer Risk in HCV-Cured Cirrhosis
Patients with cirrhosis cured of hepatitis C have a 410 times greater risk of hepatocellular carcinoma than the general population and need regular screening, researchers say. Medscape Medical News
Liquid Biopsy in HCC: Valuable Tool for Detection, Monitoring
Further research is needed, though, to overcome barriers to the routine clinical use of liquid biopsy for patients with hepatocellular carcinoma (HCC). Medscape Medical News
Immunotherapy Treatment Shows Promise for Resectable Liver Cancer
Perioperative immunotherapy appears to be safe in the setting of resectable hepatocellular carcinoma, according to findings from an open-label phase 2 clinical trial. Medscape Medical News
Drug Combo Ups Ulcer Risk After Cryoablation in Patients With HCC
Patients with hepatocellular carcinoma should be switched from a PD-1, TKI combination to monotherapy after cryoablation. The study was published as a preprint and has not yet been peer reviewed. First Look
